A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

All existing shareholders including Alexandria Venture Investments contributed to the RNA drug developer’s series B round, following a $91.5m series A in mid-2020.

All existing shareholders contributed to the Marine Biological Laboratory spinout’s series B round, following a $91.5m series A in mid-2020.

Harel contributed to drug discovery technology developer Eikon Therapeutics' $518m series B round while a host of corporates are set to exit data management software provider Trifacta in a $400m acquisition.

Nexon has invested $400m in film and television studio Agbo while responsible credit card provider Petal raised $140m in an Encore Bank and Cuna Mutual-backed round.

Veon and Prosus helped B2B product marketplace ShopUp push its series B funding to $109m while Sunshine Insurance backed rounds for ImmuneOnco and Xuanzhu Biopharmaceutical.

Baidu Ventures has backed the small molecule cancer therapy developer’s latest round, which came after a slew of healthtech and biotech investments made by the unit in recent months.

Data storage technology producer Dera pulled in over $150m through a China Unicom-backed series C round while GlobalBees raised in excess of $110m in a round featuring SoftBank and FirstCry.

Multiple corporates have helped staffing software provider Paradox close a $200m series C round, and electronic parts maker BOE Technology is putting up about $47m in a Chinese state-backed vehicle.